Stonepine Capital Management’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-54,975
Closed -$149K 79
2025
Q1
$149K Sell
54,975
-48,693
-47% -$145K 0.15% 54
2024
Q4
$315K Sell
103,668
-34,836
-25% -$115K 0.25% 43
2024
Q3
$476K Buy
+138,504
New +$498K 0.3% 31

Other funds holding PYPD

Stonepine Capital Management's PYPD Position: Q2 2025 in Review

Stonepine Capital Management sold out of PolyPid (PYPD) in Q2 2025, closing a stake of 54,975 shares — an estimated $149K sold.

Stonepine Capital Management first reported a position in PYPD in Q3 2024 and held it in 3 quarters. The position peaked at $476K in Q3 2024. 15 funds tracked by Wall St. Rank hold PYPD as of Q2 2025.

  • Stonepine Capital Management reported no remaining PolyPid position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 54,975 PolyPid shares in Q2 2025, an estimated $149K.
  • Stonepine Capital Management first reported a position in PolyPid in Q3 2024 and held it in 3 quarters.
  • Stonepine Capital Management's PolyPid position peaked at $476K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held PolyPid as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.